Percutaneous Transhepatic Cholangiography and Drainage is an Effective Rescue Therapy for Biliary Complications in Liver Transplant Recipients Who Fail Endoscopic Retrograde Cholangiopancreatography  by Hung, Hung-Hsu et al.
J Chin Med Assoc • August 2009 • Vol 72 • No 8 395
Introduction
Biliary complications are common after liver trans-
plantation and can cause significant morbidity and
mortality.1,2 The incidence of biliary complications
after liver transplantation has been reported to affect
from 10% to 30% of liver transplant patients.3 Such
complications include stricture, leakage, casts, sludge,
stones, and sphincter of Oddi dysfunction.4 Strictures
and leaks are the most common biliary complications
after liver transplantation. The incidence in cadaver
liver transplantation has been reported to be less than
10%, but it can be up to 30% in living donor liver
transplantation (LDLT).3,5–8 Biliary strictures can be
classified into anastomotic strictures (AS) and non-
anastomotic strictures (NAS). Anastomotic stricture
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is caused by technical factors such as uneven distribu-
tion or tension of the sutures. Nonanastomotic stric-
ture is due to immunologic and ischemic factors, and
graft loss.4 The 2 types of strictures cannot be com-
pared because of inherent differences in their pathol-
ogy, time to presentation, treatment, and response to
treatment.4
LDLT was first performed by Nagasue et al in Japan
in 1989.9 Despite improvements in surgical techniques,
development of immunosuppressive drugs, and better
organ preservation, the rate of biliary complications
remains unchanged.10,11 Biliary complication manage-
ment includes a combination of endoscopic, radiologic
and surgical procedures.12 Endoscopic management
of AS is successful in 70–100% of cases; however, with
NAS, the rate of success drops to 50–75%.4 In LDLT,
the success rate is 60–75% for patients with AS and
25–33% for those with NAS.4 Percutaneous transhep-
atic drainage is considered to be second-line treatment
for biliary complications after endoscopic retrograde
cholangiopancreatography (ERCP) failure.
We retrospectively reviewed the patients and eval-
uated: (1) the factors that predispose patients to de-
velop biliary complications after liver transplantation;
and (2) the effectiveness of percutaneous transhepatic
cholangiography and drainage (PTCD) or ERCP for
the management of these complications.
Methods
Patients
We retrospectively reviewed the chart records of con-
secutive patients who received liver transplantation 
in the Division of General Surgery at Taipei Veterans
General Hospital between February 2003 and June
2008. A total of 81 cases of adults who received liver
transplants during that time were included in the
study.
Biliary complications were suspected when: (1)
there was at least 1 clinical finding (fever, leukocytosis,
abdominal pain, peritonitis, cholangitis, sepsis); (2) the
drainage tube showed biliary staining; or (3) abdomi-
nal sonography, computed tomography (CT), ERCP,
or magnetic resonance cholangiopancreatography re-
vealed a problem, including biliary tract dilatation, stric-
ture, or leakage. Suspected complications were then
confirmed by PTCD or ERCP.
ERCP method
All patients receiving ERCP were mildly sedated. After
receiving a 10-mL simethicone drop, 8% lidocaine was
locally sprayed into the back of the patient’s throat.
Patients then received 40 mg intramuscular injection
of hyoscine-N-butylbromide (Buscopan®; Boehringer
Ingelheim GmbH, Ingelheim, Germany). Then, a side-
view endoscope (JF-260; Olympus, Tokyo, Japan)
was passed into the descending duodenum and selec-
tive cannulation with a 5-Fr cannula (PK-109Q-1;
Olympus) was performed. Cholangiograms and pan-
creaticograms were obtained by injecting contrast into
the common bile duct and pancreatic duct, respectively,
under fluoroscopy.
When bile leakage was detected, use of a naso-
biliary catheter (NBC) was indicated. A 0.025-inch,
450-cm microinvasive Teflon®-coated guidewire (Hydra
Jagwire® Guidewire; Boston Scientific, Boston, MA,
USA) with a 3-cm flexible tip was inserted via the can-
nula into the common bile duct. After withdrawal of the
cannula over the guidewire, a 6.5-Fr NBC (ENBD-
6.5-LEUNG-7; Cook Inc., Bloomington, IN, USA)
was inserted into the biliary system over the guidewire.
The endoscope was removed gradually without dis-
placing the catheter.
If the cholangiogram revealed biliary stricture, bil-
iary stenting was considered. When indicated, a stent
was placed after balloon dilatation; 1 or 2 8.5-Fr plas-
tic stents (Flexima™ Biliary Stent System; Boston
Scientific) were then inserted.
PTCD method
Under sonographic guidance, we directly punctured
the intrahepatic duct with a 22-guage Chiba needle
(Cook Inc.) via a right intercostal approach. Then, chol-
angiography was performed, and anastomotic stricture
or leakage was identified. A 0.018-Fr guidewire was
inserted through the Chiba needle, and then we dilated
the tract with a 4-Fr dilator. Next, we introduced a 
4-Fr KMP catheter (Cook Inc.) and negotiated through
the stricture with a 0.035-Fr stiff guidewire (Terumo
Corp., Tokyo, Japan). Next, the tract was dilated with
a 9-Fr dilator, and an 8-Fr angiosheath (Cordis Corp.,
Miami, FL, USA) was introduced into the bile duct
with the tip just distal to the anastomotic stricture.
We dilated the narrow segment with a 5- to 40-mm
ATB balloon catheter (Cook Inc.) and then inserted
an 8.3-Fr 32 side-hole ring catheter (Cook Inc.) with
its tip crossing the stenosis in the distal common 
bile duct.
PTCD revision was performed after 2 weeks. The
original tract was confirmed and an 8-Fr angiosheath
was advanced and the narrowed segment was dilated
with an 8- to 40-mm ATB balloon catheter. After dila-
tation, the 12-Fr silicone catheter could be advanced
smoothly to the tip of the distal common bile duct. 
If no catheter-related abdominal pain was found, once
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or twice a week, an ever-larger catheter was inserted,
until a 20-Fr silicone catheter could be inserted.
Follow-up
Serum aspartate aminotransferase, alanine aminotrans-
ferase, total bilirubin and alkaline phosphatase levels
were measured prior to the procedures, and patients
were followed up once or twice a week, depending on
their condition. After they were discharged from the
hospital, they were followed in our outpatient depart-
ment every 2–4 weeks, again depending on their 
condition. All ERCP image files were reviewed by 
1 gastroenterologist. All PTCD procedures were per-
formed and reviewed at our hospital by the same radi-
ologist. The surgeon decided whether to perform
ERCP or PTCD on an individual basis when biliary
complications first occurred. The first case of biliary
complication, managed by PTCD, was performed in
April 2003. Before March 2006, PTCD was the first
consideration for the management of biliary compli-
cations after liver transplantation. After we reviewed
studies in the field, we decided that ERCP would be
the treatment of choice for these patients. Now, ERCP
is used first to manage biliary complications in our
hospital.
Statistical analysis
Statistical analyses were performed using the χ2 test
and independent t test, where appropriate. A p value
< 0.05 was considered statistically significant. All ana-
lyses were performed with SPSS version 12.0 (SPSS
Inc., Chicago, IL, USA) for Windows.
Results
A total of 81 adult patients received liver transplanta-
tion in our hospital (Table 1). We reviewed all the
patients’ medical records and found that 49.4% of
patients had received LDLT. After liver transplanta-
tion, 18 (22.2%) patients developed biliary complica-
tions (Figure 1). The characteristics of the 18 patients
are shown in Table 2. The mean age was 53.6 years.
The most common reason for liver transplantation
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Table 1. Factors correlated with biliary complications before liver transplantation*
Parameters
Patients without biliary Patients with biliary
p
complications (n = 63) complications (n = 18)
Age (yr) 51.5 ± 11.3 53.6 ± 8.9 0.481
Sex (male:female) 38:25 13:5 0.518
Albumin 3.0 ± 0.5 3.2 ± 0.6 0.201
Creatinine 1.5 ± 1.2 1.1 ± 0.4 0.215
Total bilirubin 6.7 ± 9.0 10.2 ± 10.9 0.174
Prothrombin time (INR) 1.4 ± 0.5 1.7 ± 0.8 0.150
MELD score 17.9 ± 8.0 19.7 ± 8.5 0.418
Donor-to-recipient ratio (living:cadaver) 27:36 13:5 0.035
*Data expressed as mean ± standard deviation or n. INR = international normalized ratio; MELD = Model for End-stage Liver Disease.
Total: 81 patients
Biliary complications (n = 18)
PTCD alone (n = 8):
Cases 1, 2, 4*, 6, 7†, 9, 10, 12
ERCP success
(n = 2): Cases 14, 16
ERCP failure but PTCD success
(n = 4): Cases 3, 8, 15, 17
Died after ERCP and
PTCD (n = 2): Cases 11, 13
(n = 2) Died after ERCP: Case 5
Conservative treatment: Case 18
ERCP (n = 10)
Figure 1. Courses of the 18 patients who had biliary complications. *The 4th case received long-term PTCD implantation because 1
branch of the bile duct was totally ligated during operation; †the 7th patient received conservative treatment after PTCD failure. PTCD =
percutaneous transhepatic cholangiography and drainage; ERCP = endoscopic retrograde cholangiopancreatography.
among these patients was chronic hepatitis-related
liver cirrhosis. The interval between transplantation
and development of complications was defined as the
time from the operation date to the date of ERCP or
PTCD. This interval could be as short as 1.4 weeks or
as long as 77.7 weeks. The most common finding on
imaging was anastomotic stricture, followed by biliary
leakage.
We managed all these patients with the procedures
as shown in Figure 1. When biliary complications were
found, the surgeon in charge determined the initial
intervention treatment. Some patients received ERCP
first. If ERCP failed, PTCD was arranged.
Eight patients received PTCD initially, and 6 cases
were successfully managed. Among those 6 patients,
the PTCD was removed after biochemical data re-
turned to normal and no stricture or leakage was found
on cholangiography.
Ten patients received ERCP initially. ERCP was
attempted but failed in the 18th patient due to severe
pyloric stenosis. After conservative treatment, no com-
plication was found after the abdominal drainage tube
was removed. The 5th patient was diagnosed with bile
leakage noted on ERCP and died from sepsis not re-
lated to ERCP. The 14th and 16th patients were suc-
cessfully managed with ERCP alone. The 14th patient
was diagnosed with anastomotic bile leak by ERCP,
and an NBC was inserted. The NBC was removed
smoothly without any complications. The 16th patient
was diagnosed with anastomotic stricture and leak by
ERCP. A plastic stent was inserted, and he was dis-
charged smoothly without any complications.
After ERCP failed, PTCD was arranged, and the
biliary complications in 4 patients (Cases 3, 8, 15, and
17) were successfully managed. These patients were all
successfully managed after receiving PTCD treatment.
The drainage tubes were successfully inserted in the
11th and 13th patients. However, both died, due to
hepatitis C virus reactivation and graft rejection,
respectively.
The overall mortality rate in these patients with bil-
iary complications after liver transplantation was 16.7%.
We analyzed the characteristics of the patients with bil-
iary complications (Table 2). Biochemical data, includ-
ing Model for End-stage Liver Disease scores, cannot
predict biliary complications after liver transplantation.
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Table 2. Characteristics of the 18 patients with biliary complications after liver transplantation
No. Sex
Age MELD 
Operation cause Donor Complication Method Cause of death
(yr) score
1 F 61 26.2 HBV with LC LDLT AS PTCD
2 F 43 15.0 Secondary biliary LDLT AS PTCD
cirrhosis
3* F 61 10.9 HCV + HCC LDLT Leak ERCP PTCD
4* F 60 22.8 HBV with LC LDLT Leak + total PTCD
occlusion
5 F 62 16.6 HCV with LC LDLT Leak ERCP Sepsis
6 M 42 18.5 HBV + HCC Cadaver AS PTCD
7 M 60 34.1 HBV + HCV LDLT AS + NAS PTCD Con
8* M 60 19.0 HBV + HCC LDLT Leak + AS ERCP PTCD
9 M 37 35.3 Fulminant hepatitis Cadaver AS PTCD
(HBV)
10 M 45 18.4 HCV + HCC LDLT Leak PTCD + operation
11* M 44 15.0 HCV with LC LDLT Leak + AS ERCP PTCD HCV hepatitis
12 M 61 9.6 HBV with LC Cadaver AS PTCD
13* M 48 32.0 HBV with LC Cadaver AS ERCP PTCD Graft rejection
14 M 45 28.2 Fulminant hepatitis LDLT Leak ERCP†
(HBV)
15* M 66 17.5 HBV + HCC LDLT AS ERCP PTCD
16 M 53 10.4 HBV with LC LDLT Leak + AS ERCP‡
17* M 60 6.4 HBV + HCC + Cadaver Leak + AS ERCP PTCD
cholangiocarcinoma
18* M 56 18.6 HBV + HCC LDLT Leak ERCP Con
*ERCP failure cases (see Table 3); †the patient received ERCP with nasobiliary catheter insertion; ‡the patient received ERCP with plastic stent insertion.
F = female; M = male; HBV = hepatitis B virus; LC = liver cirrhosis; HCV = hepatitis C virus; HCC = hepatocellular carcinoma; LDLT = living donor liver transplan-
tation; AS = anastomotic stricture; NAS = non-anastomotic stricture; PTCD = percutaneous transhepatic cholangiography and drainage; ERCP = endoscopic
retrograde cholangiopancreatography; Con = conservative treatment.
Only LDLT was a risk factor of biliary complication
after liver transplantation (p = 0.035).
Discussion
LDLT is more common in Taiwan than in Western
countries, largely due to cultural differences. In our
study, 49.4% of patients received LDLT (Table 1).
Biliary complications are common after a liver trans-
plant.13 Many studies have attempted to identify pre-
disposing factors and new ways to avoid and to resolve
such complications. Eighteen patients with biliary com-
plications were found after we retrospectively reviewed
their medical charts (Figure 1).
In a study by Qian et al, preoperative serum biliru-
bin levels and living donor liver grafts were found to
be independent risk factors of biliary complications
after liver transplantation.14 Others have reported con-
flicting results.15 Biochemical markers cannot be used
to predict biliary complications after liver transplanta-
tion (Table 1). Our data revealed that LDLT is a risk
factor for biliary complications (p = 0.035). The most
common cause of biliary complication is anastomotic
stricture (Table 2). The relatively short length and
small diameter of the living donor bile duct result in
technical difficulties and a higher rate of anastomotic
stricture.
Although 1 center demonstrated excellent results
with surgical management alone for treatment of biliary
complications,16 ERCP before surgery is still the first
choice for managing biliary complications after liver
transplantation due to its noninvasive nature.17,18 Sur-
gical intervention is the treatment of choice for signif-
icant biliary anastomotic disruptions, massive biliary
leaks, or any biliary complication associated with severe
intra-abdominal or systemic infection.19
Most biliary complications after liver transplanta-
tion can be appropriately managed with ERCP.20,21
However, a significant number of patients need other
approaches.22 PTCD may be the first choice of rescue
therapy because of its high success rate.23 All the ERCP
failures in our study are shown in Table 3. Severe anas-
tomotic stricture was the most common cause of ERCP
failure in our hospital (Table 3). When the anastomotic
stricture is severe, the ERCP guidewire is difficult to
cannulate through the anastomotic stricture, as has
been shown in previous studies.18 Therapeutic proce-
dures cannot be performed because the operator is
unable to pass the guidewire through the stenotic site.
When severe anastomotic leaks are combined with
anastomotic stricture, surgical repair is suggested.
The higher rate of LDLT, which is more common in
Taiwan than in Western countries, also contributes to
the higher rate of ERCP failure. In this retrospective
study, the first case of biliary complication, managed
by PTCD, was performed in April 2003. After March
2006, ERCP became the first choice for therapy of
biliary complications. However, ERCP is a relatively
difficult procedure, requiring a longer learning curve.
In addition, the limited number of cases and lack of
experience with using ERCP after liver transplanta-
tion may have contributed to the high failure rate at
our hospital.
It is difficult to use ERCP to treat patients who
have previously undergone hepaticojejunostomy. In 
a recent study, PTCD was reported to be an effective
alternative treatment for post-hepaticojejunostomy
stricture following LDLT.24 In our experience, most
of the intrahepatic bile ducts were not dilated when
biliary complications were diagnosed. The absence 
of enlarged intrahepatic biliary ducts should not be a
contraindication to PTCD.25 Eight patients received
PTCD initially, and 6 of these patients had successful
implantations (Figure 1). Six ERCP-failed patients re-
ceived PTCD, and the procedure was successful in 
4 of these patients. The drainage tubes were success-
fully inserted in the remaining 2 patients; unfortu-
nately, they died after hepatitis C virus reactivation
and graft rejection, respectively. From a recent study,
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Table 3. Causes of endoscopic retrograde cholangiopancreatography (ERCP) failure
Case ERCP failure causes Rescue management Result
3 Guidewire could not pass the anastomotic stricture PTCD A
8 Surgical repair was suggested due to severe leakage and AS PTCD A
11 Prolonged use of NBC, then PTCD was inserted PTCD D*
13 Angulation over bile duct anastomosis PTCD D†
15 Total occlusion of the bile duct PTCD A
17 Guidewire could not pass the anastomotic stricture PTCD A
18 Endoscope could not pass due to severe pyloric deformity Conservative treatment A
*Died after reactivation of hepatitis C virus; †died after graft rejection. AS = anastomotic stricture; NBC = nasobiliary catheter; PTCD = percutaneous trans-
hepatic cholangiography and drainage; A = alive; D = dead.
PTCD may serve as a successful rescue procedure in
failed cases of endoscopic therapy for post-LDLT bil-
iary stricture.23 Our experience disclosed a high suc-
cess rate of initial treatment and rescue therapy after
endoscopic treatment failure in liver transplantation-
related biliary complication.
When we compared the total bilirubin levels be-
tween patients who received PTCD initially (group 1)
or after ERCP failure (group 2), there was no signifi-
cant difference in recovery between the 2 groups after
3 months (Figure 2). In group 1, the 6th and 10th
patients had extremely high baseline total bilirubin
levels. The 6th patient underwent liver transplantation
in March 2003. Because we had less experience in 
the management of biliary complications, PTCD was
arranged until abdominal sonography revealed dilata-
tion of the intrahepatic ducts. The 10th patient had
narrowing of the portal vein with liver function impair-
ment after liver transplantation. Bile stain was found in
the external drainage tube and total bilirubin level was
increased from 9.8 mg/dL to 29.5 mg/dL in 1 week.
Then, biliary leakage and stenosis were diagnosed.
PTCD was successfully inserted and exploratory lapa-
rotomy with abscess debridement was also performed
on the same day.
In our study, 22% of the liver transplant recipients
had biliary complications. Biochemical markers, in-
cluding Model for End-stage Liver Disease score,
could not predict biliary complications preoperatively.
LDLT poses a higher risk of biliary complications.
PTCD is an effective rescue method for managing
biliary complications if ERCP has failed. Finally, when
determining the best approach for managing patients
with biliary complications, the experience of the staff
and available facilities in each transplant center should
be considered.
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